We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Inflammatory Heart Protein May Be Drug Target

By Biotechdaily staff writers
Posted on 02 Jun 2006
Heart disease researchers have identified a gene linked to the production of an inflammatory protein critically involved in the development of ischemic heart disease (IHD).

Previous research had shown that inflammation mediated by monocyte chemoattractant protein-1 (MCP-1) played a critical role in the development of IHD. More...
However, the molecular events caused by MCP-1 binding to its receptor CCR2, and their possible role in the development of IHD was not understood.

Investigators at the University of Central Florida (Orlando, USA) worked with a mouse model that mimicked human IHD. Initially, they showed that MCP-1 binding to CCR2 induced a novel transcription factor (MCP-induced protein [MCPIP]) that caused cell death. Expression of MCP-1 in muscle fiber in mice caused death by heart failure at six months of age. MCPIP expression increased in parallel with the development of ventricular dysfunction. In situ hybridization revealed the presence of MCPIP transcripts in muscle fiber, and immunohistochemistry showed that MCPIP was associated with the nuclei of apoptotic heart cells.

The authors wrote in the May 12, 2006, issue of Circulation that, "These results provide a molecular insight into how chronic inflammation and exposure to MCP-1 contributes to heart failure and suggest that MCPIP could be a potential target for therapeutic intervention.”



Related Links:
University of Central Florida

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
HPV Test
Allplex HPV28 Detection
New
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.